A semi‐mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin

Abstract

The model proposed effectively describes the complex PK of dabigatran and takes into account drug-drug interactions with P-gp activity modulators, such as clarithromycin.